Chief executive of Macmillan Cancer Support, Ciaran Devane said:
Lung cancer patients deserve better. It is high time we closed the gap between survival rates for different cancers and give everyone the best possible chance of recovery.
Firstly, we support the call for plain packaging of cigarettes to stop people taking up smoking, secondly we must catch the illness earlier through better awareness and we have to make sure access to surgery is more uniform across the country to reduce inequalities in cancer survival.
It cannot be right that you are much more likely to get the surgery you need if you live in Leicestershire than if you live in Lancashire.
– Chief executive of Macmillan Cancer Support Ciaran Devane
The number of people dying from three common cancers - breast, prostate and bowel - is expected to almost halve by the end of the decade, according to findings from a leading health charity.
Over a third, 36%, of breast cancer sufferers will succumb to the disease, a 61% drop in the mortality rate from 1992, Macmillian Cancer Support found.
A further 39% of people with bowel cancer would die, down from 67% in 1992.
However, the lung cancer mortality rate remains high, with 76% of patients expected to die from the disease, compared to 91% in 1992.
Professor Jane Maher, chief medical officer of Macmillan Cancer Support, said: "People diagnosed with three of the four most common cancers are more likely to survive but GPs need more support to help them diagnose lung cancer earlier."
Bowel cancer screening improves the chance of catching the disease early and gives patients a 90% chance of surviving, a health campaigner has said.
Chief executive of the charity Beating Bowel Cancer, Mark Flannagan, remained sceptical about research which claimed a lot of colonoscopies were unnecessary and urged people to get checked.
If bowel cancer is detected at an early stage, there is over a 90% chance of it being successfully treated.
This is why taking part in the bowel cancer screening programme is so important. If you have an abnormal result you'll be sent for a colonoscopy to detect polyps, which can develop into cancer over time.
Whilst this study raises reasonable questions about the need to remove all polyps which are found, much more research needs to be done to refine the choice of which polyps should be routinely removed in the future.
– chief executive Beating Bowel Cancer Mark Flannagan
We're very worried that the clock is ticking for future bowel cancer patients.
The uncertainty around how these drugs will be funded in the years to come will mean patients who could benefit from having treatment in the future, may be denied access because the money isn't there to fund it.
It is vital that the funding remains in place to ensure that bowel cancer patients will continue to get access to the drugs which their doctors say they need on the NHS.
Without it we fear patients' lives will be put at risk. We simply can't go backwards to a time when cancer patients had to beg for life-extending treatment.
– Mark Flannagan, Chief Executive of Beating Bowel Cancer